We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Upholds Most of $76M Award In Apotex-AstraZeneca Patent Case
Court Upholds Most of $76M Award In Apotex-AstraZeneca Patent Case
The Federal Circuit affirmed most of a 2013 U.S. district court ruling that ordered Apotex to pay AstraZeneca slightly more than $76 million for infringing on patents for its heartburn drug Prilosec.